Bruce Ganem

Dr. Ganem, Chief Scientific Officer and co-founder of KensaGroup, is the Franz and Elisabeth Roessler Professor of Chemistry and the J.
Thomas Clark Professor of Entrepreneurship at Cornell University.
Dr. Ganem received his B.A. degree in chemistry from Harvard College and his Ph.D in organic chemistry from Columbia University.
After completing postdoctoral work at Stanford, he joined the Cornell faculty in 1974, serving as department chairman from 1993 to 1997 and again in 2001.
A synthetic organic chemist by training, Dr. Ganem has broad scientific research interests ranging from organic and analytical chemistry to biochemistry and molecular medicine, including medicinal chemistry, structure-based drug design, protein engineering, and biotechnology.
His current research focuses on new chemical processes known as multicomponent reactions, which have important applications to drug discovery and development.
Dr. Ganem has authored over 240 scientific papers, and holds five patents.
He is the recipient of numerous awards and honors, including the 1999 Chemical Manufacturers Association National Catalyst Award and the 2007 American Chemical Society Award for Creative Invention.
As a scientist-entrepreneur, Dr. Ganem has founded or helped start several biopharmaceutical and technology companies in the past fifteen years, including LeukoSite, ArQule, Natural Pharmaceuticals, Inc., Taktix, KensaGroup, Gene Network Sciences, NovaSterilis, Medhesives, North Sea Resins, and Novomer.